Precipio Gross Margin 2011-2025 | PRPO
Current and historical gross margin for Precipio (PRPO) over the last 10 years. The current gross profit margin for Precipio as of June 30, 2025 is %.
| Precipio Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $0.02B | $0.01B | 42.86% |
| 2025-03-31 | $0.02B | $0.01B | 47.37% |
| 2024-12-31 | $0.02B | $0.01B | 47.06% |
| 2024-09-30 | $0.02B | $0.01B | 43.75% |
| 2024-06-30 | $0.02B | $0.01B | 43.75% |
| 2024-03-31 | $0.02B | $0.01B | 37.50% |
| 2023-12-31 | $0.02B | $0.01B | 37.50% |
| 2023-09-30 | $0.01B | $0.01B | 35.71% |
| 2023-06-30 | $0.01B | $0.00B | 27.27% |
| 2023-03-31 | $0.01B | $0.00B | 33.33% |
| 2022-12-31 | $0.01B | $0.00B | 37.50% |
| 2022-09-30 | $0.01B | $0.00B | 37.50% |
| 2022-06-30 | $0.01B | $0.00B | 50.00% |
| 2022-03-31 | $0.01B | $0.00B | 50.00% |
| 2021-12-31 | $0.01B | $0.00B | 37.50% |
| 2021-09-30 | $0.01B | $0.00B | 25.00% |
| 2021-06-30 | $0.01B | $0.00B | 12.50% |
| 2021-03-31 | $0.01B | 0 | 0.00% |
| 2020-12-31 | $0.01B | 0 | 0.00% |
| 2020-09-30 | $0.01B | 0 | 0.00% |
| 2020-06-30 | $0.00B | 0 | 0.00% |
| 2020-03-31 | $0.00B | 0 | 0.00% |
| 2019-12-31 | $0.00B | 0 | 0.00% |
| 2019-09-30 | $0.00B | 0 | 0.00% |
| 2019-06-30 | $0.00B | 0 | 0.00% |
| 2019-03-31 | $0.00B | 0 | 0.00% |
| 2018-12-31 | $0.00B | 0 | 0.00% |
| 2018-09-30 | $0.00B | 0 | 0.00% |
| 2018-06-30 | $0.00B | 0 | 0.00% |
| 2018-03-31 | $0.00B | 0 | 0.00% |
| 2017-12-31 | $0.00B | 0 | 0.00% |
| 2017-09-30 | $0.00B | $0.00B | 100.00% |
| 2017-06-30 | $0.00B | $0.00B | 100.00% |
| 2017-03-31 | $0.00B | $0.00B | 50.00% |
| 2016-12-31 | $0.00B | $0.00B | 50.00% |
| 2016-09-30 | $0.00B | 0 | 0.00% |
| 2016-06-30 | $0.00B | 0 | 0.00% |
| 2016-03-31 | $0.00B | 0 | 0.00% |
| 2015-12-31 | $0.00B | 0 | 0.00% |
| 2015-09-30 | $-0.02B | $-0.01B | 53.33% |
| 2015-06-30 | $-0.01B | $-0.01B | 54.55% |
| 2015-03-31 | $0.00B | $0.00B | 100.00% |
| 2014-12-31 | $0.00B | $0.00B | -200.00% |
| 2014-09-30 | $0.02B | $0.01B | 34.78% |
| 2014-06-30 | $0.03B | $0.01B | 30.77% |
| 2014-03-31 | $0.03B | $0.01B | 34.62% |
| 2013-12-31 | $0.03B | $0.01B | 37.04% |
| 2013-09-30 | $0.03B | $0.01B | 35.71% |
| 2013-06-30 | $0.03B | $0.01B | 41.38% |
| 2013-03-31 | $0.03B | $0.01B | 45.16% |
| 2012-12-31 | $0.03B | $0.01B | 45.16% |
| 2012-09-30 | $0.03B | $0.02B | 51.52% |
| 2012-06-30 | $0.03B | $0.02B | 51.52% |
| 2012-03-31 | $0.03B | $0.02B | 53.13% |
| 2011-12-31 | $0.03B | $0.02B | 56.25% |
| 2011-09-30 | $0.03B | $0.02B | 53.57% |
| 2011-06-30 | $0.02B | $0.01B | 54.17% |
| 2011-03-31 | $0.02B | $0.01B | 47.62% |
| 2010-12-31 | $0.02B | $0.01B | 47.37% |
| 2010-09-30 | $0.02B | $0.01B | 47.62% |
| 2010-06-30 | $0.02B | $0.01B | 50.00% |
| 2010-03-31 | $0.02B | $0.01B | 54.55% |
| 2009-12-31 | $0.02B | $0.01B | 54.55% |
| 2009-09-30 | $0.02B | $0.01B | 57.14% |
| 2009-06-30 | $0.02B | $0.01B | 57.14% |
| 2009-03-31 | $0.02B | $0.01B | 59.09% |
| 2008-12-31 | $0.02B | $0.01B | 60.87% |
| 2008-09-30 | $0.02B | $0.02B | 62.50% |
| 2008-06-30 | $0.02B | $0.02B | 62.50% |
| 2008-03-31 | $0.02B | $0.01B | 58.33% |
| 2007-12-31 | $0.02B | $0.01B | 56.52% |
| 2007-09-30 | $0.02B | $0.01B | 54.55% |
| 2007-06-30 | $0.02B | $0.01B | 50.00% |
| 2007-03-31 | $0.02B | $0.01B | 50.00% |
| 2006-12-31 | $0.02B | $0.01B | 47.83% |
| 2006-09-30 | $0.02B | $0.01B | 45.45% |
| 2006-06-30 | $0.02B | $0.01B | 45.83% |
| 2006-03-31 | $0.03B | $0.01B | 44.00% |
| 2005-12-31 | $0.03B | $0.01B | 42.31% |
| 2005-09-30 | $0.03B | $0.01B | 37.93% |
| 2005-06-30 | $0.03B | $0.01B | 30.00% |
| 2005-03-31 | $0.03B | $0.01B | 28.13% |
| 2004-12-31 | $0.03B | $0.01B | 26.47% |
| 2004-09-30 | $0.04B | $0.01B | 28.57% |
| 2004-06-30 | $0.04B | $0.01B | 28.57% |
| 2004-03-31 | $0.03B | $0.01B | 29.41% |
| 2003-12-31 | $0.04B | $0.01B | 31.43% |
| 2003-09-30 | $0.04B | $0.01B | 34.29% |
| 2003-06-30 | $0.04B | $0.02B | 41.67% |
| 2003-03-31 | $0.04B | $0.02B | 45.95% |
| 2002-12-31 | $0.04B | $0.02B | 48.65% |
| 2002-09-30 | $0.04B | $0.02B | 51.28% |
| 2002-06-30 | $0.04B | $0.02B | 55.00% |
| 2002-03-31 | $0.04B | $0.02B | 53.66% |
| 2001-12-31 | $0.04B | $0.02B | 53.85% |
| 2001-09-30 | $0.04B | $0.02B | 54.29% |
| 2001-06-30 | $0.03B | $0.02B | 51.61% |
| 2001-03-31 | $0.03B | $0.01B | 51.85% |
| 2000-12-31 | $0.03B | $0.01B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.032B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Enovis (ENOV) | United States | $1.765B | 9.27 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Azenta (AZTA) | United States | $1.370B | 59.76 |
| Phreesia (PHR) | United States | $1.350B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |